Waters Corporation's ability to collect accounts receivable sequentially worsen to 4.38, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Waters's Accounts Receivable average collection period in the Jul 04 2026 quarter, has increased to 83 days, from 72 days, in the Apr 04 2026 quarter.

If we take a look into Healthcare sector 382 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jul 04 2026 from 2235 to 2332.

What is Receivable Turnover Ratio?
What is Waters Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

WAT Receivables Turnover Ratio	(Jul 04 2026) II. Quarter	(Apr 04 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Receivable Change	172.16 %	-5.65 %	13.02 %	4580.29 %	5061.72 %
Y / Y Revenue Change	113.27 %	91.48 %	6.83 %	8.05 %	8.86 %
Receivable Turnover Ratio (TTM)	4.38	5.06	4.19	4.25	5.56
WAT's Total Ranking	# 2332	# 2235	# 2680	# 1349	# 0
Accounts Receivable average collection period days	83	72	87	86	66
Seq. Receivable Change	195.25 %	-18.8 %	10.73 %	2.53 %	2.35 %
Seq. Revenue Change	29.83 %	35.89 %	16.56 %	3.7 %	16.57 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 16
Healthcare Sector	# 383
Overall Market	# 2332

Receivable Turnover Ratio Statistics
High	Average	Low
0.96	0.66	-0.37
(Jun 30 2023)		(Sep 30 2019)

WAT Company Profile • Back to WAT Efficiency Comparisons • Compare WAT Receivables Turnover Ratio to its Competitors

Financial Statements
Waters's Accounts Receivable	$ 1,987 Millions	Visit WAT's Balance sheet
Waters's Sales TTM	$ 4,644 Millions	Visit WAT's Income Statement
Sources of WAT's Revenues		Visit WAT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
WAT's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
WAT's Growth Rates	WAT's Roa	WAT's Inventory Turnover Ratio	WAT's Dividend Comparisons
WAT's Profitability Ratios	WAT's Roi	WAT's Asset Turnover Ratio	WAT's Dividend Growth
WAT's Valuation Ratios	WAT's Roe	WAT's Financial Strength Ratios	WAT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jul 04 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jul 04 2026	Receivable at quarter ending Jul 04 2026
Baxter International Inc	6.43	$ 11,555.000 Millions	$ 1,798.000 Millions
Healthcare Services Group Inc	6.42	$ 1,864.594 Millions	$ 290.515 Millions
Verastem Inc	6.42	$ 87.526 Millions	$ 13.640 Millions
Haemonetics Corporation	6.42	$ 1,351.722 Millions	$ 210.662 Millions
Macrogenics Inc	6.41	$ 167.674 Millions	$ 26.170 Millions
Bruker Corporation	6.41	$ 3,498.900 Millions	$ 546.100 Millions
Adaptive Biotechnologies Corporation	6.38	$ 308.081 Millions	$ 48.254 Millions
Iradimed Corporation	6.38	$ 86.339 Millions	$ 13.533 Millions
Aquestive Therapeutics Inc	6.37	$ 54.087 Millions	$ 8.489 Millions
Zoetis Inc	6.32	$ 9,517.000 Millions	$ 1,506.750 Millions
Nuwellis Inc	6.28	$ 9.013 Millions	$ 1.435 Millions
Puma Biotechnology Inc	6.27	$ 231.244 Millions	$ 36.902 Millions
Absci Corp	6.24	$ 1.561 Millions	$ 0.250 Millions
Insulet Corporation	6.24	$ 3,053.400 Millions	$ 489.200 Millions
Heartflow Inc	6.22	$ 210.791 Millions	$ 33.872 Millions
Perrigo Company Plc	6.22	$ 4,144.000 Millions	$ 666.050 Millions
Maxcyte inc	6.22	$ 31.051 Millions	$ 4.994 Millions
Vertex Pharmaceuticals Inc	6.19	$ 12,587.200 Millions	$ 2,032.400 Millions
Orthofix Medical Inc	6.17	$ 833.344 Millions	$ 135.037 Millions
Harvard Bioscience Inc	6.16	$ 88.164 Millions	$ 14.306 Millions
Genedx Holdings Corp	6.16	$ 455.446 Millions	$ 73.962 Millions
Gilead Sciences Inc	6.15	$ 30,457.000 Millions	$ 4,951.000 Millions
Integra Lifesciences Holdings Corp	6.14	$ 1,647.666 Millions	$ 268.153 Millions
Clearpoint Neuro Inc	6.13	$ 42.279 Millions	$ 6.902 Millions
Interpace Biosciences Inc	6.12	$ 36.519 Millions	$ 5.963 Millions
Xeris Biopharma Holdings Inc	6.12	$ 335.414 Millions	$ 54.800 Millions
Treace Medical Concepts Inc	6.12	$ 205.307 Millions	$ 33.551 Millions
Cadre Holdings inc	6.11	$ 686.540 Millions	$ 112.443 Millions
Zevra Therapeutics Inc	6.09	$ 128.855 Millions	$ 21.172 Millions
Femasys Inc	6.08	$ 2.299 Millions	$ 0.378 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.